They were working on it, we invested in several private placements. According to the company they were not notified in advance as to the patent approval by the patent office and they only found out about it through a press release.
The previous FDA approval of the new method of making the compound was huge, and this patent is a much stronger patent now.
$2.00 is alot different than if they were forced to raise all the money at .75. In fact, I know the CEO was in NY meeting with a friend of mine and I am sure with a bunch of investment banks. Oppenheimer did the last raise.
I hope they do some type of strategic alliance and never have to worry about money raises again. The depression area had been a wasteland for a decade but now there are new classes of drugs that appear to be alot safer with little or no side effects, this one could be the gem of them all.
Check out the website, a video explains the way the drug works.
News 
Market Data 
Discover 
